Dr. Preetam Shah

Dr. Preetam Shah oversees Elicio’s strategic planning and financial operations, developing and implementing the company’s strategic initiatives and providing related advice to the board of directors and company management. Prior to joining Elicio, he served as Chief Financial Officer and Chief Business Officer of Cidara Therapeutics, a publicly traded biotechnology company, where he oversaw multiple corporate financings and business development transactions, and helped guide its corporate strategy. Prior to Cidara, Dr. Shah served as Executive Vice President, Chief Financial Officer and Treasurer for Brainstorm Cell Therapeutics, a publicly traded biotechnology company, where he directed and implemented key financing strategies and corporate initiatives. Additionally, Dr. Shah has held senior roles as an investment banker at Barclays Capital PLC and Canaccord Genuity Inc., where he advised healthcare companies on equity, debt, and M&A transactions. As the founder of Saisarva LLC, a healthcare consulting firm, Dr. Shah executed and negotiated numerous licensing deals with pharmaceutical companies and consulted for healthcare-focused private equity and hedge funds. Additionally, Dr. Shah served as Vice President, U.S. Operations and Investments, at Reliance Capital USA Ventures, an affiliate of Reliance ADA Group Companies, where he was responsible for guiding early-stage venture investments.

Dr. Shah holds a Ph.D. in microbiology from the University of Mississippi Medical Center and an MBA in finance from the Wharton School, University of Pennsylvania. He completed a post-doctoral fellowship in infectious diseases from Stanford University School of Medicine.

In his free time Preetam enjoys watching sports, playing cricket and tennis, traveling to new places, and spending time with his family.